Get personalized medicine

Precision Medicine means tailoring medical treatments to the individual characteristics of each patient.

Today, physicians are able to target the unique nature of an individual patient’s tumor by matching treatments at the molecular level, resulting in improved outcome.

Already in 2011, a study from MD Anderson Cancer Center found that patients with advanced cancers treated with the traditional or standard of care, which is based on their type or origin of cancer rather than their DNA tumor profile, had a mere 5% response rate to their treatment.

The same study found that when patients with metastatic cancers were treated using a personalized approach, matching them at the molecular level, there was a 27% response rate.This was the beginning of personalized medicine using DNA. OmiCure™ goes one step further using RNA and it is available now.
DISCOVER OMICURE™

What results can I expect?

Based on your personal results, your oncologist may propose a targeted therapy.

Alternatively, with the help of OmiCure™, the physician may avoid using a therapy which may not have the intended efficacy for you. This will prevent unnecessary adverse events from an ineffective therapy.

Using all information at hand, the oncologist may propose to continue the same therapy in the same oncology center, using the standard of care, or to have access to experimental therapies through your participation in clinical trials for these therapies.

OmiCure™ cannot determine whether a specific therapy is the right one for treatment, or predict the response of a specific patient to any specific therapy. The OmiCure™ report is not a source of medical advice for a patient or to have patients make treatment decisions on their own. Instead, information in the OmiCure™ report will exclusively guide discussions between a patient and his or her oncologist
OmiCure  cancer Tumor Profiling genomic DNA & RNA AI test  - artificial Inteligence
OmiCure  cancer Tumor Profiling genomic DNA & RNA AI test  - artificial InteligenceOmiCure  cancer Tumor Profiling genomic DNA & RNA AI test  - artificial InteligenceOmiCure  cancer Tumor Profiling genomic DNA & RNA AI test  - artificial Inteligence

Your oncologist needs Omicure™

It would take years for your oncologist to sort through all of the information publicly available about the latest FDA-approved and experimental therapies and published research, and accumulate all of the information available to make accurate decisions.

OmiCure™ provides oncologists with a clear report about available therapies based on information collected at the genomic level. This report is designed to provide a concise, actionable summary and other information for your oncologist. Ultimately, the report enables the patient and caregiving team to make informed treatment decisions.

Why is the current standard of care not working?

There are multiple standards of care in the treatment of cancer in different parts of the world.

These differ on the basis of:
- local medical experience translated into medical practice
- limitations for coverage in different healthcare systems
- access to information about potential therapies available elsewhere.

Patients with the same cancer diagnosis are unlikely to share the same specific tumor genomes and are also unlikely to have the same exact responses to identical treatments. Cancer must be viewed as a personal disease, with personalized precision treatments to best treat each specific disease.
OmiCure  cancer Tumor Profiling genomic DNA & RNA AI test  - artificial InteligenceOmiCure  cancer Tumor Profiling genomic DNA & RNA AI test  - artificial Inteligence
OmiCure  cancer Tumor Profiling genomic DNA & RNA AI test  - artificial Inteligence

Does the report show hereditary cancer risks?

The OmiCure™ report does not include information on congenital cancer risks. The genomic information included  in this report includes only mutations in the tumor genome, and gene expression differences between the patient’s tumor and a healthy reference cohort.